{\rtf1\ansi\ansicpg1252\cocoartf2821
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx720\tx1440\tx2160\tx2880\tx3600\tx4320\tx5040\tx5760\tx6480\tx7200\tx7920\tx8640\pardirnatural\partightenfactor0

\f0\fs24 \cf0 \{\
  "Site of Recurrence": \{\
    "Confirmed nodal or distant recurrence": \{\
      "Isolated inguinofemoral/pelvic LN recurrence": \{\
        "Step": "Consider resection of clinically enlarged and suspicious LN(s)",\
        "Therapy for Recurrence": \{\
          "No prior EBRT": \{\
            "Action": [\
              "EBRT + concurrent chemotherapy",\
              "\uc0\u8594  Surveillance (VULVA-8)"\
            ]\
          \},\
          "Prior EBRT": \{\
            "Action": [\
              "Systemic therapy and/or",\
              "Selective EBRT if feasible or",\
              "Best supportive care (NCCN Guidelines for Palliative Care)"\
            ]\
          \}\
        \}\
      \},\
      "Distant metastasis or Prior pelvic EBRT": \{\
        "Therapy for Recurrence": [\
          "Systemic therapy and/or",\
          "Selective EBRT if feasible or",\
          "Best supportive care (NCCN Guidelines for Palliative Care)"\
        ]\
      \}\
    \}\
  \}\
\}\
}